TARDBP and amyotrophic lateral sclerosis: The significant elevation of plasma TDP‐43 in the ALS group agrees with one case–control study.4 The previous measurement of plasma TDP‐43 based on conventional immunoassay failed to accurately quantify more than 70% of samples due to insufficient sensitivity.4, 25 In contrast, we could detect measurable signals from the whole plasma samples.